RE:RE:Speaking factuallyThey aren't focused on the same operational path, and Cronos is massively overvalued right now. Pointing out a company that has a laughable valuation as a peer to compare too is erroneous. However, I assume much of its valuation has to do with its 2.4 billion dollar strategic investment from Altria, who probably sought large buildout capacity and saw synergies with a conglomerate like Cronos.
Supreme is not focused on capacity as much as other market players. They are focused on a single brand, and highly focused on quality flower. That differentiates them from other companies product mixes.
If you are that concerned, you should not be investing in a highly speculative sector.
Like I said, I invest based on facts, not conjecture, not other companies valuations.